How Do We Measure Cost-Effectiveness in Cancer Treatments?
Cost-effectiveness is assessed using metrics such as the Quality-Adjusted Life Year (QALY) and the Incremental Cost-Effectiveness Ratio (ICER). These tools help determine the value of medical interventions by comparing the costs to the health outcomes they produce. In cancer care, assessing cost-effectiveness is vital due to the high price of innovative therapies and targeted treatments.